NCT07117136View on ClinicalTrials.gov

Blinatumomab Consolidation in Real World

Not yet recruitingOBSERVATIONAL

Enrollment

200

Participants

Timeline

Start Date

September 1, 2025

Primary Completion Date

May 14, 2029

Study Completion Date

May 14, 2029

Conditions

B-Cell Acute Lymphoblastic Leukaemia

All Listed Sponsors

lead

Medical College of Wisconsin

OTHER